These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29491295)

  • 1. Portal-systemic Encephalopathy due to Complicated Spleno-renal Shunt Successfully Treated with Balloon-occluded Retrograde Transvenous Obliteration Using a Double Coaxial Balloon Catheter System and Shape-memory Coils.
    Matsuoka S; Yamana Y; Ishii T; Kumagawa M; Mizutani T; Kamimura S; Matsumoto N; Nakamura H; Nirei K; Tatsuo K; Moriyama M
    Intern Med; 2018 Jul; 57(13):1861-1866. PubMed ID: 29491295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus-associated decompensated liver cirrhosis with refractory hepatic encephalopathy successfully treated by balloon-occluded retrograde transvenous obliteration after sofosbuvir/velpatasvir.
    Takakusagi S; Shimizu M; Yokoyama Y; Kizawa K; Marubashi K; Kosone T; Sato K; Kakizaki S; Takagi H; Uraoka T
    Clin J Gastroenterol; 2020 Dec; 13(6):1303-1309. PubMed ID: 32914297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of balloon-occluded retrograde transvenous obliteration (B-RTO) performed in a patient with primary biliary cirrhosis with severe recurrent hepatic encephalopathy due to splenorenal shunt.
    Takashimizu S; Watanabe N; Kojima S; Kagawa T; Mine T; Myojin K; Koizumi J
    Tokai J Exp Clin Med; 2007 Jul; 32(2):70-4. PubMed ID: 21319062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balloon-occluded retrograde transvenous obliteration (BRTO) for a direct shunt between the inferior mesenteric vein and the inferior vena cava in a patient with hepatic encephalopathy.
    Ibukuro K; Sugihara T; Tanaka R; Fukuda H; Abe S; Tobe K; Tateishi R; Tagawa K
    J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):121-5. PubMed ID: 17296712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic encephalopathy from dual splenorenal shunts treated with balloon-occluded retrograde transvenous obliteration by using a double-balloon technique.
    Matake K; Tajima T; Yoshimitsu K; Irie H; Aibe H; Nishie A; Asayama Y; Honda H
    J Vasc Interv Radiol; 2007 Nov; 18(11):1436-40. PubMed ID: 18003996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful portal-systemic shunt occlusion with balloon-occluded retrograde transvenous obliteration for portosystemic encephalopathy without liver cirrhosis.
    Tanaka O; Ishihara K; Oyamada H; Harusato A; Yamaguchi T; Ozawa M; Nakano K; Yamagami T; Nishimura T
    J Vasc Interv Radiol; 2006 Dec; 17(12):1951-5. PubMed ID: 17185692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful control of portal hypertension-related complications after two embolization procedures for multiple and large spontaneous portosystemic shunts in a patient with liver cirrhosis.
    Ueno W; Sato N; Miura K; Morimoto N; Watanabe S; Nomoto H; Isoda N; Kijima S; Kikuchi T; Manaka S; Mori H; Yamamoto H
    Clin J Gastroenterol; 2021 Aug; 14(4):1227-1232. PubMed ID: 33993428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portal-systemic shunt between the inferior mesenteric vein and inferior vena cava in a patient with hepatic encephalopathy: successful occlusion by balloon-occluded retrograde transvenous obliteration.
    Kakizawa H; Toyota N; Hieda M; Ishikawa M; Tanitame K; Tani C; Okazaki A; Takaki S; Aikata H; Chayama K; Awai K
    Hiroshima J Med Sci; 2011 Mar; 60(1):15-9. PubMed ID: 21675043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous use of plug-assisted and coil-assisted retrograde transvenous obliteration for treating refractory hepatic encephalopathy in a patient with two portosystemic shunts: A case report.
    Ju SG; Lee JM; Shim J
    Medicine (Baltimore); 2023 Jun; 102(22):e33961. PubMed ID: 37266629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term results of balloon-occluded retrograde transvenous obliteration for portosystemic shunt encephalopathy in patients with liver cirrhosis and portal hypertension.
    Inoue H; Emori K; Toyonaga A; Oho K; Kumamoto M; Haruta T; Mitsuyama K; Tsuruta O; Sata M
    Kurume Med J; 2014; 61(1-2):1-8. PubMed ID: 25420513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal bleeding after balloon-occluded retrograde transvenous obliteration: a case report.
    Furue Y; Hidaka H; Fujii K; Matsunaga K; Koizumi W
    J Med Case Rep; 2015 Mar; 9():62. PubMed ID: 25886049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful splenorenal shunt occlusion with balloon-occluded retrograde transvenous obliteration yielded improvement of residual liver function, enabled administration of direct-acting antivirals, and achieved sustained virological response to hepatitis C virus: A case report.
    Ochi H; Aono M; Takechi S; Mashiba T; Yokota T; Joko K
    J Dig Dis; 2017 Feb; 18(2):125-129. PubMed ID: 28102583
    [No Abstract]   [Full Text] [Related]  

  • 13. Effective balloon-occluded retrograde transvenous obliteration of the superior mesenteric vein-inferior vena cava shunt in a patient with hepatic encephalopathy after living donor liver transplantation.
    Baimakhanov Z; Soyama A; Takatsuki M; Inoue Y; Matsushima H; Hidaka M; Kitasato A; Adachi T; Kuroki T; Sakomoto I; Eguchi S
    Clin J Gastroenterol; 2014 Aug; 7(4):342-5. PubMed ID: 26185885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effect of balloon-occluded retrograde transvenous obliteration on portal-systemic encephalopathy in patients with liver cirrhosis.
    Kato T; Uematsu T; Nishigaki Y; Sugihara J; Tomita E; Moriwaki H
    Intern Med; 2001 Aug; 40(8):688-91. PubMed ID: 11518103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver stiffness measured by transient elastography as predictor of prognoses following portosystemic shunt occlusion.
    Ishikawa T; Sasaki R; Nishimura T; Matsuda T; Maeda M; Iwamoto T; Saeki I; Hidaka I; Takami T; Sakaida I
    J Gastroenterol Hepatol; 2019 Jan; 34(1):215-223. PubMed ID: 30070412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intrahepatic portosystemic venous shunt via right renal vein successfully treated with balloon-occluded retrograde transvenous obliteration].
    Hashiguchi K; Yamasaki K; Ichikawa T; Takeshima F; Nakao K
    Nihon Shokakibyo Gakkai Zasshi; 2011 Oct; 108(10):1726-34. PubMed ID: 21971147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience.
    Mukund A; Rajesh S; Arora A; Patidar Y; Jain D; Sarin SK
    J Vasc Interv Radiol; 2012 Sep; 23(9):1200-6. PubMed ID: 22832139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of balloon-occluded retrograde transvenous obliteration with ethanolamine oleate for the treatment of hepatic encephalopathy in a cirrhotic patient with a large spontaneous splenorenal shunt.
    Numata K; Tanaka K; Kiba T; Saito S; Shirato K; Kitamura T; Sekihara H
    J Gastroenterol; 1998 Jun; 33(3):424-7. PubMed ID: 9658325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of surgical splenorenal shunt-related hepatic myelopathy with endovascular interventional techniques.
    Wang MQ; Liu FY; Duan F
    World J Gastroenterol; 2012 Dec; 18(47):7104-8. PubMed ID: 23323015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis.
    Lee SJ; Kim SU; Kim MD; Kim YH; Kim GM; Park SI; Won JY; Lee DY; Lee KH
    J Gastroenterol Hepatol; 2017 Aug; 32(8):1487-1494. PubMed ID: 28085232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.